Stockholders' Equity - Narrative (Details) - USD ($)		1 Months Ended			9 Months Ended
	Aug. 03, 2023	Sep. 30, 2023	Aug. 31, 2023	Jul. 31, 2023	Sep. 30, 2023	Sep. 30, 2022	May 12, 2023	May 11, 2023	Dec. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Issuance of shares of common stock for compensation (in shares)			80,000
Shares Issued, Price Per Share			$ 1.25
Stock compensation expense					$ 373,786	$ 520,416
Share-based compensation expense not yet recognized, options		$ 700,000			700,000
Warrants Not Settleable in Cash, Fair Value Disclosure		$ 145,000			145,000				$ 2,595
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock compensation expense					$ 300,000	$ 100,000
Horizon Well Testing Case
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares settled (in shares)	250,000			250,000
Shares Issued, Price Per Share				$ 1.99
Class C Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, shares authorized (in shares)		15,000,000			15,000,000				15,000,000
Common stock, shares outstanding (in shares)		1,501,840			1,501,840				1,529,888
Common stock, shares issued (in shares)		1,501,840			1,501,840				1,529,888
Stock converted (in shares)		26,749
Class A Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, shares authorized (in shares)		200,000,000			200,000,000		200,000,000	295,000,000	200,000,000
Common stock, shares outstanding (in shares)		24,331,406			24,331,406		22,504,669	180,037,350	22,303,333
Common stock, shares issued (in shares)		24,331,406			24,331,406		22,504,669	180,037,350	22,303,333
Conversion of stock, shares issued (in shares)		26,749